Tome Biosciences Inc.
Tome is a company dedicated to innovative solutions in its field, aiming to revolutionize the industry with cutting-edge technology and a clear vision for the future.
Industries
Nr. of Employees
medium (51-250)
Tome Biosciences Inc.
Products
Integrase-Mediated PGI (I-PGI)
A technology for integrating large DNA sequences (>1,000 base pairs) into the genome at user-defined locations using a proprietary integrase.
Ligase-Mediated PGI (L-PGI)
A technology for integrating small DNA sequences (1-100s of base pairs) into the genome at user-defined locations using a DNA ligase.
Integrative Gene Therapy for PKU
A gene therapy approach to treat phenylketonuria (PKU) by inserting a healthy copy of the PAH gene into its natural genomic location.
Integrative Gene Therapy for ASCVD
A gene therapy approach to treat atherosclerotic cardiovascular disease (ASCVD) by increasing the expression of the ApoA-1 gene.
Integrative Gene Therapy for HCU
A gene therapy approach to treat homocystinuria (HCU) by inserting a healthy copy of the CBS gene into its natural or a defined genomic location.
Integrative Gene Therapy for Hereditary Hemochromatosis
A gene therapy approach to treat hereditary hemochromatosis by editing the HFE gene to address iron overload.
Integrase-Mediated PGI (I-PGI)
A technology for integrating large DNA sequences (>1,000 base pairs) into the genome at user-defined locations using a proprietary integrase.
Ligase-Mediated PGI (L-PGI)
A technology for integrating small DNA sequences (1-100s of base pairs) into the genome at user-defined locations using a DNA ligase.
Integrative Gene Therapy for PKU
A gene therapy approach to treat phenylketonuria (PKU) by inserting a healthy copy of the PAH gene into its natural genomic location.
Integrative Gene Therapy for ASCVD
A gene therapy approach to treat atherosclerotic cardiovascular disease (ASCVD) by increasing the expression of the ApoA-1 gene.
Integrative Gene Therapy for HCU
A gene therapy approach to treat homocystinuria (HCU) by inserting a healthy copy of the CBS gene into its natural or a defined genomic location.
Integrative Gene Therapy for Hereditary Hemochromatosis
A gene therapy approach to treat hereditary hemochromatosis by editing the HFE gene to address iron overload.
Services
Request for page content
I do not have the ability to fetch external webpages. Please paste the textual content (About, Capabilities, Products, Technical details, regulatory statements, etc.) from the provided URL so I can extract a structured company profile.
Request for page content
I do not have the ability to fetch external webpages. Please paste the textual content (About, Capabilities, Products, Technical details, regulatory statements, etc.) from the provided URL so I can extract a structured company profile.